Anda di halaman 1dari 13

Future

Acute
Event

Prevention

Screening Diagnosis

of Cancer:
Monitoring

Treatment
Plus

Chronic
Disease

Emerging Technology Trends


Impacting Cancer Care

Ogan Gurel, MD MPhil


Aesis Research Group, LLC
gurel@aesisgroup.com

ACI Cancer Conference


San Diego
February 9th, 2007
Outline

 Change
 The Future of Cancer
 Impact on Cancer Care
Competitive forces cause
change
•Hospitals / ASCs

• Relaxation of CON

• Aging of the population

•Emphasis of baby-boomers
on convenience and
• Growing influence of device seamlessness
companies
• Consumer-directed health
• Relative physician/surgeon plans
shortages
• Growing influence of
• Physician work-life balance Federal government
issues
• Emphasis on quality
measures

• BBA II?

• Technology convergence

• Convergence of diagnosis and treatment

Source: Porter, Michael, On Competition, 1995 • Emerging technologies


Change can be
incremental or disruptive

Source: Christensen, Clayton et al, Seeing What’s Next, 2004


Outline

 Change
 The Future of Cancer
 Impact on Cancer Care
The hospital as center of
care

Acute
Event

Diagnosis Treatment

Chronic
Disease
Care is now decentralized
and fragmented
Acute
Event

Prevention

Screening Diagnosis Monitoring

Treatment
Plus

Chronic
Disease
The future will demand more
integration and coordination

Acute Prevention
Event

Sub-
Screening Diagnosis
Diagnosis

Treatment
Monitoring
Plus
Chronic
Disease
Substitutes

• Technology convergence

• Convergence of diagnosis and treatment

Source: Porter, Michael, On Competition, 1995 • Emerging technologies – esp. disruptive ones
Key disruptive technologies

 Earlier Diagnosis

 Targeted therapies

 Personalized Medicine

 Minimally Invasive Surgery/Intervention


Outline

 Change
 The Future of Cancer
 Impact on Cancer Care
Imperatives for Future Cancer Care
 Provide coordinated, seamless care among multi-specialty providers
 Address increasingly complex conditions and must address more than
just the medical / surgical problem
 Consider alliances and partnerships to help address these challenges
 Measure quality
 “Ride the IT wave” or be rendered irrelevant
 Increasingly consider the integration of imaging (and diagnosis) with
therapeutic care cases
 Be increasingly aware that the federal government (Medicare, etc.) are
not just “bystanders” in the process. Regulation and compliance are
critical
 Keep costs down – reimbursements will not be increasing and may very
well decrease (though without compromising quality)
 Keep physicians happy … which is not always about money
 Be flexible enough to accommodate technology changes
Æsis Research Group
Ogan Gurel, MD MPhil
Chairman
Providing forward-looking information, intelligence and
research services to healthcare investment decision-makers

Facilitating hospital-clinician relationships to help implement


and move forward strategic, operational and facilities initiatives

T (312) 246-5160| F (773) 409-5897

gurel@aesisgroup.com